Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : NP Energy Cp New -- Ignore unavailable to you. Want to Upgrade?

To: John7777 who wrote (17692)	5/24/1999 9:29:00 AM
From: cgstocks	Read Replies (1) \| Respond to of 22810

You guys are hilarious!! Lets continue the run today and get back to the focus of succeeding....For those interested, (ot) BICO news was out early this morning and is huge!!!! Watch this stk soar...FDA approval = $$$$ Biocontrol Submits Module for Diasensor to FDA PITTSBURGH--(BUSINESS WIRE)--May 24, 1999--Biocontrol Technology Inc. (OTC BB:BICO) announced today that the first module of its modular premarket approval application (PMA) submission for the Diasensor 2000 was submitted to the FDA. This module contains a description of Biocontrol Technology's manufacturing methods, facilities and controls, including design controls as required by FDA regulations. The FDA approved Biocontrol's PMA Shell submission in mid-April of this year. The Diasensor 2000 noninvasive glucose monitor is similar to the Diasensor 1000 model with enhancements to the operating software and hardware. Biocontrol Technology has its corporate offices in Pittsburgh, and is involved in the development and manufacture of biomedical devices and environmental products. Biocontrol has the exclusive rights to the research and development and manufacturing of the Diasensor 2000. Subsidiary Diasensor.com Inc., also located in Pittsburgh, owns the patent, marketing and distribution rights to the sensor. WEB SITE: www.bico.com INVESTOR RELATIONS NEWSLINE NUMBER: 800/357-6204 CONTACT: Biocontrol Technology Inc., Pittsburgh Investors: Diane McQuaide, 412/429-0673 Media: Susan Taylor, 412/429-0673 KEYWORD: PENNSYLVANIA BW1056 MAY 24,1999 5:15 PACIFIC 8:15 EASTERN